FluroTest Provides Clinical Trial Update for High Volume COVID-19 Rapid Antigen Testing System
CALGARY, AB, May 10, 2021 /PRNewswire/ - FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF) and wholly owned subsidiary "FluroTest" or The Company), a diagnostics technology leader in high output rapid antigen testing for the detection of SARS-CoV-2 and other pathogens, today announces the next phase of its ongoing clinical trials with its trial partner Toolbox Medical Innovations ("Toolbox"). The Company is pleased to report that approximately 600 volunteer participants, including both symptomati...
United States Rhode Island Melina Cimler Flurotest Diagnostics Systems Ltd Corporation Annual Information Form Drug Administration
Source: prnewswire.com